| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00429-015-1125-5 |
| P698 | PubMed publication ID | 26462663 |
| P2093 | author name string | D Gagnon | |
| Martin Parent | |||
| T Di Paolo | |||
| L Gregoire | |||
| P2860 | cites work | Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey | Q28270776 |
| Distribution of serotonin 5-HT(2A) receptors in afferents of the rat striatum | Q31911250 | ||
| Serotonergic heterotypic sprouting in the unilaterally dopamine-depleted mouse neostriatum | Q31927557 | ||
| Levodopa motor complications in Parkinson's disease | Q34070854 | ||
| Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. | Q34187994 | ||
| Brain serotonin transporter binding in non-depressed patients with Parkinson's disease | Q34619565 | ||
| Spared caudal brainstem SERT binding in early Parkinson's disease | Q34724279 | ||
| Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen | Q35117445 | ||
| The human raphe nuclei and the serotonergic system. | Q35631866 | ||
| Parkinson's disease: pathophysiology | Q36495393 | ||
| Involvement of the serotonin system in L-dopa-induced dyskinesias | Q37200059 | ||
| The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease | Q37260910 | ||
| Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias | Q37260948 | ||
| Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients | Q37602233 | ||
| Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations. | Q38218100 | ||
| Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. | Q40790760 | ||
| L-Dopa-Induced Release of Cerebral Monoamines | Q41522173 | ||
| Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study | Q42443875 | ||
| Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. | Q42477740 | ||
| Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey | Q42481728 | ||
| Serotonin innervation of human basal ganglia | Q42484813 | ||
| Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea | Q42489819 | ||
| Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study | Q42994792 | ||
| Distribution and ultrastructural features of the serotonin innervation in rat and squirrel monkey subthalamic nucleus | Q43117323 | ||
| Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease | Q43185554 | ||
| Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum | Q43557117 | ||
| Clinical-pathological study of levodopa complications | Q43938511 | ||
| Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine | Q44150493 | ||
| Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications | Q44351567 | ||
| Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease | Q44459079 | ||
| Positron emission tomography of striatal serotonin transporters in Parkinson disease | Q44585433 | ||
| Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys | Q44790368 | ||
| Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years | Q45155172 | ||
| Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. | Q46490885 | ||
| Alterations in serotonin signalling are involved in the hyperactivity of Pitx3-deficient mice. | Q46794636 | ||
| Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice | Q48031051 | ||
| Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter | Q48121057 | ||
| Quantitative and ultrastructural study of serotonin innervation of the globus pallidus in squirrel monkeys | Q48152997 | ||
| Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats | Q48192232 | ||
| Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents | Q48231652 | ||
| Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats | Q48234068 | ||
| Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram | Q48276587 | ||
| Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. | Q48345542 | ||
| Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen. | Q48363578 | ||
| Serotonergic sprouting in primate MTP-induced hemiparkinsonism. | Q48389315 | ||
| High and low affinity [3H]imipramine binding sites in control and parkinsonian brains. | Q48444210 | ||
| Immunohistochemical demonstration of serotonin nerve fibers in the corpus striatum of the rat, cat and monkey. | Q48564667 | ||
| Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats. | Q48565695 | ||
| MPTP alters central catecholamine neurons in addition to the nigrostriatal system | Q48597136 | ||
| The neuropathologic basis of different clinical subgroups of Parkinson's disease. | Q48633612 | ||
| Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. | Q48737270 | ||
| Pathological basis for neurotransmitter changes in Parkinson's disease | Q48857336 | ||
| L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice. | Q48918393 | ||
| Immunocytochemical localization of serotonin at the ultrastructural level | Q48919568 | ||
| Pre- and postsynaptic sites for serotonin modulation of GABA-containing neurons in the shell region of the rat nucleus accumbens. | Q48963102 | ||
| Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. | Q49046932 | ||
| Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. | Q49095990 | ||
| Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor | Q51116310 | ||
| P433 | issue | 7 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| serotonin | Q167934 | ||
| striatum | Q1319792 | ||
| P304 | page(s) | 3675-3691 | |
| P577 | publication date | 2015-10-13 | |
| P1433 | published in | Brain Structure and Function | Q13444883 |
| P1476 | title | Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys | |
| P478 | volume | 221 |
| Q47998172 | Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey. |
| Q55002495 | Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys. |
| Q42754446 | Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent regionally selective, bimodal effects on striatal dopamine kinetics in vivo |
| Q33715234 | Refining the Role of 5-HT in Postnatal Development of Brain Circuits |
| Q48300577 | Serotonergic targets for the treatment of L-DOPA-induced dyskinesia. |
| Q48000070 | Serotonin neuron development: shaping molecular and structural identities. |
Search more.